🔍

PLATIND - Platinum Industr

📊 NSE: PLATIND 🏢 Chemicals 📅 Last Updated: 12/14/2025 11:02

📢 Recent Corporate Announcements

Platinum Industries to Hold One-on-One Virtual Meeting with 11H Advisors on March 14

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 11 Mar 2026, 05:48 PM

Platinum Industries Limited has announced a scheduled interaction with institutional investor 11H Advisors. The one-on-one meeting is set to take place virtually on March 14, 2026. The company has explicitly stated that no unpublished price-sensitive information (UPSI) will be shared during this interaction. Such meetings are part of routine investor relations activities to discuss publicly available information and company performance.

One-on-one virtual meeting scheduled with 11H Advisors for March 14, 2026.
Interaction conducted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Company confirms that only publicly available information will be discussed during the session.
The meeting schedule is subject to change based on unforeseen exigencies.

💡 No immediate action is required as this is a routine corporate disclosure. Investors may look for any subsequent investor presentations or meeting transcripts on the company's website for insights into management's outlook.

Platinum Industries Q3 Revenue Jumps 31% YoY; Targets 35% CAGR Through FY29

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 18 Feb 2026, 11:53 AM

Platinum Industries reported a strong Q3 FY26 with standalone revenue growing 31% YoY to ₹102.62 crores, driven by robust demand in the PVC pipe and fittings segment. The company has provided aggressive guidance, targeting over 40% revenue growth in FY27 and a 35% CAGR through FY29, supported by the upcoming Egypt facility and Palghar expansion. While gross margins moderated to 31% due to a higher mix of CPVC sales, the company remains net debt-free with a PAT of ₹12.93 crores for the quarter. Furthermore, the company is diversifying into the pharma sector through its new subsidiary, Rivadu LifeSciences, expecting revenue contributions starting in FY27.

Standalone Q3 revenue rose 31% YoY to ₹102.62 Cr, while PAT increased 18% YoY to ₹12.93 Cr.
Management guided for a 35% revenue CAGR from FY26 to FY29, fueled by international expansion and new product lines.
Egypt facility construction is expected to finish by May 2026, with commercial production targeted for September 2026.
Palghar CPVC capacity is currently at 60-65% utilization, with lead-free stabilizer lines scaling up from April 2026.
Entered the pharma sector via 70% stake in Rivadu LifeSciences, focusing on niche APIs and nutraceuticals.

💡 Investors should focus on the successful commissioning of the Egypt plant and the margin trajectory as the company scales its CPVC and pharma businesses. The strong growth guidance and debt-free status make this a compelling growth play in the specialty chemicals space.

Platinum Industries Releases Recording of Q3 FY26 Earnings Conference Call

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 13 Feb 2026, 05:52 PM

Platinum Industries Limited has officially released the recording of its earnings conference call held on February 13, 2026. The call, which took place at 3:00 PM IST, follows the company's recent financial results announcement. This disclosure is mandatory under SEBI (LODR) Regulations to ensure transparency for all shareholders. Investors can now access the management's detailed commentary and responses to analyst questions via the provided web link.

Earnings conference call held on February 13, 2026, at 15:00 IST.
Recording link made available on the company's official website as per SEBI Regulation 46.
The disclosure provides equal access to management commentary for all retail and institutional investors.
Follows the company's Q3 FY26 financial performance review.

💡 Investors should listen to the recording to understand management's outlook on the PVC additives industry and any updates on capital expenditure. This is a routine but necessary step for fundamental analysis of the company's growth trajectory.

Platinum Industries: Q3 Results with Modified Auditor Opinion; New Pharma Subsidiary Approved

🔵 WATCH ⭐ 8/10

BOARD_MEETING 📅 12 Feb 2026, 05:43 PM

Platinum Industries approved its Q3 and 9M FY26 results on February 12, 2026, which notably included a modified opinion from statutory auditors PKF Sridhar and Santhanam LLP. The company is diversifying into the pharmaceutical and lifesciences sector by incorporating a new subsidiary, Rivadu Lifesciences Private Limited. Platinum Industries will hold a minimum 70% stake in this new venture with an initial capital investment of up to Rs. 25 lakh. This move marks a strategic expansion into APIs, intermediates, and specialty chemicals.

Board approved unaudited financial results for Q3 and 9M ended December 31, 2025, with a modified auditor opinion.
Incorporation of new subsidiary 'Rivadu Lifesciences Private Limited' approved for entry into the pharma sector.
Initial capital for the new subsidiary is set at up to Rs. 25,00,000 with Platinum Industries holding at least 70% stake.
The new business line will focus on APIs, pharmaceutical intermediates, excipients, and specialty chemicals.
Statutory auditors PKF Sridhar and Santhanam LLP issued the modified opinion on the financial results.

💡 Investors should carefully examine the specific details of the auditor's modified opinion to identify potential financial or governance risks. The expansion into the pharmaceutical sector should be monitored closely as it represents a significant diversification from the company's core business.

Platinum Industries Enters Pharma Sector; Q3 Results Filed with Modified Auditor Opinion

🔵 WATCH ⭐ 7/10

EXPANSION 📅 12 Feb 2026, 05:21 PM

Platinum Industries has announced a strategic diversification into the pharmaceutical and lifesciences sector through the incorporation of a new subsidiary, Rivadu Lifesciences Private Limited. The company will hold at least a 70% stake in the new venture, which has an initial capital outlay of Rs. 25 lakh. While the board approved the Q3 FY26 financial results, the statutory auditors have submitted their report with a modified opinion, which warrants investor attention. The new business line will focus on APIs, intermediates, and specialty chemicals.

Board approved Q3 FY26 financial results for the period ended December 31, 2025.
Statutory auditors PKF Sridhar and Santhanam LLP issued a report with a modified opinion.
Incorporation of new subsidiary 'Rivadu Lifesciences' for entry into the Pharma/Lifesciences industry.
Initial capital for the new subsidiary is set at up to Rs. 25,00,000.
Platinum Industries will maintain a minimum 70% controlling stake in the new entity.

💡 Investors should investigate the specific reasons behind the auditor's 'modified opinion' on the financial results as this can indicate accounting concerns. While the diversification into pharma is a growth signal, the execution and capital requirements for this new segment should be monitored closely.

Platinum Industries to Host Q3 & 9MFY26 Earnings Call on February 13, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 05 Feb 2026, 05:22 PM

Platinum Industries Limited has scheduled its post-earnings conference call for Friday, February 13, 2026, at 3:00 PM IST. The call is intended to discuss the company's unaudited financial results for the third quarter and nine months ended December 31, 2025. Senior management, including the Chairman cum Managing Director and the Chief Financial Officer, will be present to address investor queries. This is a standard regulatory procedure following the disclosure of quarterly financial performance.

Earnings call scheduled for February 13, 2026, at 15:00 IST via Zoom
Focus on unaudited financial results for Q3 and 9MFY26 ended December 31, 2025
Management representation by CMD Krishna Rana and CFO Ashok Bothra
Call coordinated by Kaptify Consulting for institutional investors and analysts

💡 Investors should review the financial results once published and may join the call to understand management's outlook on the PVC additives market and company growth. No immediate trading action is required based solely on this scheduling announcement.

Platinum Industries' Stake in Subsidiary Diluted to 89.49% Following Private Placement

🟡 NEUTRAL ⭐ 6/10

FUNDRAISE 📅 03 Feb 2026, 06:01 PM

Platinum Industries Limited has announced a change in the shareholding pattern of its subsidiary, Platinum Oleo Chemicals Private Limited. The subsidiary allotted 17,598 equity shares to new shareholders via a private placement on February 3, 2026. Consequently, Platinum Industries' stake in the subsidiary has decreased from 99.99% to 89.49%. The parent company did not participate in this allotment, resulting in a 10.5% dilution of its ownership.

Subsidiary Platinum Oleo Chemicals Private Limited issued 17,598 equity shares of Rs. 10 each.
Parent company Platinum Industries' stake reduced from 99.99% to 89.49%.
The allotment was made to new shareholders through a private placement process.
The total nominal value of the allotment is Rs. 1,75,980, though the actual capital raised may differ based on the premium.
The move follows a board meeting outcome previously dated November 13, 2025.

💡 Investors should monitor the strategic intent behind bringing new shareholders into the subsidiary and whether this precedes a larger expansion or capital expenditure plan.

Platinum Industries Files Routine SEBI Reg 74(5) Compliance for Q3 FY26

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 13 Jan 2026, 03:08 PM

Platinum Industries Limited has filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. For the quarter ended December 31, 2025, the company's Registrar and Share Transfer Agent, Bigshare Services Private Limited, reported zero dematerialization requests. This filing confirms that the share records maintained by the depositories and the company are in order. Such filings are mandatory for all listed entities to ensure transparency in shareholding records.

Quarterly compliance certificate filed for the period ending December 31, 2025.
Registrar Bigshare Services confirmed no dematerialization requests were received during the quarter.
The report covers the period from October 1, 2025, to December 31, 2025.

💡 This is a standard administrative update with no impact on stock valuation; no specific action is needed.

Platinum Industries to Close Trading Window from January 1, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 28 Dec 2025, 06:31 PM

Platinum Industries Limited has announced the closure of its trading window for all designated persons starting January 1, 2026. This routine regulatory action is taken in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the declaration of financial results for the quarter and nine months ending December 31, 2025. The trading window will remain closed until 48 hours after the board approves and publicly discloses the unaudited financial results. This measure ensures that insiders do not trade on price-sensitive information before it is available to the general public.

Trading window closure commences on Thursday, January 1, 2026.
Closure pertains to the financial results for the quarter and nine months ending December 31, 2025.
Restriction applies to all Directors, Designated Employees, and Key Managerial Personnel.
The window will reopen 48 hours after the official declaration of unaudited financial results.

💡 This is a standard regulatory procedure and requires no specific action from retail investors. Monitor the company's future announcements for the specific date of the Q3 FY26 earnings release.

View All PLATIND Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue grew 48.36% YoY to INR 3,922.61 Mn in FY25. Standalone revenue, representing the core Indian operations, grew 29.03% YoY to INR 3,248.93 Mn. For H1FY26, consolidated revenue reached INR 2,137.6 Mn, a 5.67% increase over H1FY25.

Geographic Revenue Split

India operations (Standalone) contributed approximately 82.8% of total consolidated revenue in FY25 (INR 3,248.93 Mn out of INR 3,922.61 Mn). The company is aggressively expanding into Egypt (leveraging the Suez Canal), Europe, Southeast Asia, Africa, and the Middle East.

Profitability Margins

Gross margins contracted significantly by 873 bps to 29.98% in FY25 from 38.71% in FY24 due to input cost pressures. PAT margin declined by 368 bps to 12.77% in FY25 from 16.45% in FY24. H1FY26 consolidated PAT margin stood at 12.3%.

EBITDA Margin

Consolidated EBITDA margin dropped 839 bps to 14.72% in FY25 from 23.11% in FY24. Absolute EBITDA declined 5.47% YoY to INR 577.56 Mn. H1FY26 consolidated EBITDA margin further moderated to 13.4% compared to 17.6% in H1FY25.

Capital Expenditure

The company is investing in a new manufacturing unit at Palghar with an estimated installed capacity of 60,000 MTPA, expected to be operational during FY26. This facility focuses on modernizing production for non-lead-based stabilizers.

Credit Rating & Borrowing

The company is near debt-free with a debt-to-equity ratio of 0.01. It maintains a robust interest coverage ratio of 25.27x, indicating very low borrowing costs and high solvency.

⚙️ Operational Drivers

Raw Materials

Petrochemicals represent the primary raw material component. Cost of Goods Sold (COGS) rose to INR 2,746.68 Mn in FY25, accounting for 69.49% of total revenue compared to 61.29% in the previous year.

Import Sources

Not disclosed in available documents, though the company mentions strategic sourcing and international operations in Egypt.

Capacity Expansion

Current capacity not explicitly stated in total MT; however, the company is adding 60,000 MTPA of capacity at its Palghar unit for non-lead-based stabilizers, scheduled for FY26 completion.

Raw Material Costs

Raw material costs (COGS) increased 69.5% YoY to INR 2,746.68 Mn in FY25. The company manages this through long-term supplier relationships and exploring alternative raw materials to reduce single-source dependency.

Manufacturing Efficiency

The company is transitioning to Zero Liquid Discharge (ZLD) and targeting a 30% reduction in water usage by 2025 to improve environmental efficiency.

Logistics & Distribution

Distribution strategy focuses on the Suez Canal hub to optimize global freight costs and improve delivery timelines for international markets.

📈 Strategic Growth

Expected Growth Rate

28%

Growth Strategy

Growth will be driven by the commissioning of the 60,000 MTPA Palghar facility in FY26, aggressive expansion into the Egyptian and European markets, and a strategic shift toward high-demand non-lead-based stabilizers. The company is also utilizing IPO proceeds to fund capital expenditure and maintain a low-debt balance sheet for flexibility.

Products & Services

PVC stabilizers, lead-based stabilizers, non-lead-based (eco-friendly) stabilizers, and lubricants used in industrial applications.

Brand Portfolio

Platinum Industries.

New Products/Services

New non-lead-based stabilizers are being launched to cater to the growing global demand for eco-conscious chemical alternatives.

Market Expansion

Targeting Southeast Asia, Africa, and the Middle East, with a specific focus on the Egypt facility as a gateway to global markets.

🌍 External Factors

Industry Trends

The industry is shifting toward sustainable, non-lead-based stabilizers due to environmental regulations. Platinum is positioning itself for this shift with its new 60,000 MTPA specialized unit.

Competitive Landscape

Characterized by intense competition from both domestic and international low-cost chemical manufacturers.

Competitive Moat

Moat is built on a near debt-free balance sheet (0.01 D/E), strategic geographic positioning in Egypt for low-cost global logistics, and technical transition to eco-friendly stabilizers which have higher entry barriers.

Macro Economic Sensitivity

Highly sensitive to construction and infrastructure spending cycles, as these drive the demand for PVC-based products.

Consumer Behavior

Increasing consumer and regulatory preference for lead-free and sustainable chemical additives in construction materials.

Geopolitical Risks

Operations near the Suez Canal expose the company to regional geopolitical stability risks, though the location is currently used as a strategic logistics advantage.

⚖️ Regulatory & Governance

Industry Regulations

Subject to stringent environmental and safety regulations regarding chemical formulations, particularly those involving lead-based components which are facing global restrictions.